Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
49
UTHR Quote, Financials, Valuation and Earnings
Last price:
$359.68
Seasonality move
:
6.42%
Day range:
$357.99 - $363.90
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
15.79x
P/S ratio:
6.38x
P/B ratio:
2.63x
Volume:
925.6K
Avg. volume:
333.7K
1-year change:
59.45%
Market cap:
$16.1B
Revenue:
$2.3B
EPS (TTM):
$22.77
Earnings Data
Next earnings date for UTHR
Feb 21
2025
Most recent earnings per share
$6.39
Missed by $0.73
(Oct 30/2024)
Consensus Estimate
$7.12
(Oct 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
UTHR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $743M | -- | -- | $7.10 | -- |
| 10/30/2024 | Q3 | $722.6M | $748.9M | $6.39 | $7.12 | -$0.73 |
| 07/31/2024 | Q2 | $691.9M | $714.9M | $5.85 | $6.41 | -$0.56 |
| 05/01/2024 | Q1 | $624.2M | $677.7M | $6.17 | $5.59 | $0.58 |
| 02/21/2024 | Q4 | $575.9M | $614.7M | $4.36 | $4.56 | -$0.20 |
| 11/01/2023 | Q3 | -- | -- | $5.38 | $5.31 | $0.07 |
| 08/02/2023 | Q2 | -- | -- | $5.24 | $4.78 | $0.46 |
| 05/03/2023 | Q1 | -- | -- | $4.86 | $4.71 | $0.15 |
| 02/22/2023 | Q4 | -- | -- | $2.67 | $5.21 | -$2.54 |
| 11/02/2022 | Q3 | -- | -- | $4.91 | $4.85 | $0.06 |
| 08/03/2022 | Q2 | -- | -- | $2.41 | $4.54 | -$2.13 |
| 05/04/2022 | Q1 | -- | -- | $5.03 | $3.65 | $1.38 |
| 02/24/2022 | Q4 | -- | -- | $2.35 | $4.05 | -$1.70 |
| 11/03/2021 | Q3 | -- | -- | $3.42 | $4.09 | -$0.67 |
| 08/04/2021 | Q2 | -- | -- | $3.65 | $3.56 | $0.09 |
| 05/05/2021 | Q1 | -- | -- | $0.61 | $3.49 | -$2.88 |
| 02/24/2021 | Q4 | -- | -- | $2.19 | $3.51 | -$1.32 |
| 10/28/2020 | Q3 | -- | -- | $3.84 | $3.34 | $0.50 |
| 07/29/2020 | Q2 | -- | -- | $2.41 | $3.28 | -$0.87 |
| 04/29/2020 | Q1 | -- | -- | $3.12 | $3.39 | -$0.27 |
| 02/26/2020 | Q4 | -- | -- | $1.20 | $3.47 | -$2.27 |
| 10/30/2019 | Q3 | -- | -- | $3.01 | $2.90 | $0.11 |
| 07/31/2019 | Q2 | -- | -- | $3.63 | $2.74 | $0.89 |
| 05/01/2019 | Q1 | -- | -- | $3.58 | $2.61 | $0.97 |
| 02/27/2019 | Q4 | -- | -- | $3.34 | $2.55 | $0.79 |
| 10/31/2018 | Q3 | -- | -- | $3.98 | $3.46 | $0.52 |
| 08/01/2018 | Q2 | -- | -- | $4.36 | $3.42 | $0.94 |
| 05/02/2018 | Q1 | -- | -- | $3.76 | $4.00 | -$0.24 |
| 02/21/2018 | Q4 | -- | -- | $3.89 | $4.58 | -$0.69 |
| 10/25/2017 | Q3 | -- | -- | $4.69 | $4.80 | -$0.11 |
| 07/27/2017 | Q2 | -- | -- | $4.37 | $3.66 | $0.71 |
| 04/26/2017 | Q1 | -- | -- | $3.61 | $3.82 | -$0.21 |
| 02/22/2017 | Q4 | -- | -- | $2.64 | $3.62 | -$0.98 |
| 10/27/2016 | Q3 | -- | -- | $3.63 | $3.47 | $0.16 |
| 07/28/2016 | Q2 | -- | -- | $4.52 | $3.26 | $1.26 |
| 04/28/2016 | Q1 | -- | -- | $4.84 | $3.33 | $1.51 |
| 02/25/2016 | Q4 | -- | -- | $2.21 | $2.57 | -$0.36 |
| 10/21/2015 | Q3 | -- | -- | $5.02 | $2.44 | $2.58 |
| 07/28/2015 | Q2 | -- | -- | $2.02 | $2.26 | -$0.24 |
| 04/28/2015 | Q1 | -- | -- | -- | $2.10 | -- |
| 02/24/2015 | Q4 | -- | -- | $2.61 | $2.19 | $0.42 |
United Therapeutics Earnings Questions
-
How Much did United Therapeutics Generate in Revenue Last Quarter?
United Therapeutics reported $748.9M worth of top line sales in its most recent quarter.
-
Did United Therapeutics Beat Earnings Last Quarter?
United Therapeutics announced earnings per share of $6.39 which represents a miss of analyst forecast a $7.12 per share.
-
Is United Therapeutics Profitable?
United Therapeutics reported $665.8M that represents $13.76 per share over the last quarter.
-
What is the Analyst Consensus for United Therapeutics EPS Next Year?
United Therapeutics's earnings are forecast to grow from $19.81 per share to $20.23 per share next year representing an increase of 35.94%.
-
When is United Therapeutics's Earnings Date?
United Therapeutics's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.55% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
